Oruka Therapeutics Announces Preclinical Data for ORKA-001 at the European Academy of Dermatology and Venereology Congress
September 25, 2024 07:08 ET
|
Oruka Therapeutics, Inc.
Half-life in non-human primates (NHP) of 30.3 days after subcutaneous (SQ) administration and 33.8 days after intravenous (IV) administration Equivalent potency to risankizumab with similar binding...
Kymera Therapeutics Presents Preclinical Data for KT-621, a Potent, Selective, First-In-Class, Oral STAT6 Degrader at the EADV Congress
September 25, 2024 07:00 ET
|
Kymera Therapeutics, Inc.
KT-621 has the potential to provide dupilumab-like activity with an oral small molecule profile for TH2 driven allergic and atopic disease KT-621 demonstrated strong degradation of STAT6 in human...
Steakholder Foods® Signs Commercial Sales Agreement for its Plant-Based Premixes with Bondor Foods
September 25, 2024 07:00 ET
|
STEAKHOLDER FOODS LTD.
Agreement Enables Bondor Foods to Launch Production of White Fish Kebab and Salmon Patties Developed Using Steakholder Foods’ Premixes, Marking Transition to Large-Scale Manufacturing Rehovot,...
Eightco Announces $100 million Revenue Forecast – Releases 2025 Strategic Plan
September 25, 2024 07:00 ET
|
Eightco Holdings Inc.
Improved Financial Condition Allows Focus on Revenue Growth & Profitability Easton, PA, Sept. 25, 2024 (GLOBE NEWSWIRE) -- Eightco Holdings Inc. (NASDAQ: OCTO) (the “Company” or “Eightco”)...
Apellis Pharmaceuticals to Host a Fireside Chat at the UBS Virtual Ophthalmology Day
September 25, 2024 07:00 ET
|
Apellis Pharmaceuticals, Inc.
WALTHAM, Mass., Sept. 25, 2024 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the company will host a fireside chat at the UBS Virtual Ophthalmology Day on...
Climb Channel Solutions Announces A-LIGN, Security and Compliance Partner, as Global Contract
September 25, 2024 07:00 ET
|
Climb Channel Solutions
EATONTOWN, N.J., Sept. 25, 2024 (GLOBE NEWSWIRE) -- Climb Channel Solutions, an international specialty technology distributor and wholly owned subsidiary of Climb Global Solutions, Inc. (NASDAQ:...
Johnson Outdoors Announces Cash Dividend
September 25, 2024 06:00 ET
|
Johnson Outdoors Inc.
RACINE, Wisc., Sept. 25, 2024 (GLOBE NEWSWIRE) -- Johnson Outdoors Inc. (Nasdaq: JOUT), a leading global innovator of outdoor recreation equipment and technology, today announced approval by its...
ChampionX Publishes 2023 Sustainability Report
September 25, 2024 06:00 ET
|
ChampionX Corporation
ChampionX Corporation (Nasdaq: CHX) announces the release of its 2023 corporate sustainability report.
Alvotech hefur klíníska rannsókn á AVT16, fyrirhugaðri líftæknilyfjahliðstæðu við Entyvio
September 25, 2024 05:01 ET
|
Alvotech
Alvotech er einn tveggja aðila sem vitað er að hafi byrjað klíníska rannsókn á sjúklingum fyrir fyrirhugaða líftæknilyfjahliðstæðu við Entyvio (vedolizumab)Á síðustu tólf mánuðum, fram til loka...
Alvotech Initiates Confirmatory Patient Study for AVT16, a Proposed Biosimilar to Entyvio®
September 25, 2024 05:01 ET
|
Alvotech
Alvotech is one of two companies known to have initiated a global or multi-country confirmatory patient study for a biosimilar candidate to Entyvio®Sales of Entyvio (vedolizumab) were about $5.4...